Two of the world’s largest pharmaceutical companies are locked in a bidding war for the maker of a weight-loss drug that ...
Investor's Business Daily on MSN
Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera
Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.
Novo Nordisk on Thursday launched an unsolicited bid valued at up to $9 billion for obesity-drug developer Metsera, hoping to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback